Vir Biotechnology (VIR) Net Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | -42.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.94 Mn |
| Dec 31, 2025 | 77,824.00 |
| Sep 30, 2025 | -5.90 Mn |
| Jun 30, 2025 | -463,977.00 |
| Mar 31, 2025 | -386,335.00 |
| Dec 31, 2024 | -15,438.00 |
| Sep 30, 2024 | -278,747.00 |
| Jun 30, 2024 | 62,961.00 |
| Mar 31, 2024 | 9,754.00 |
| Dec 31, 2023 | -48,522.00 |
| Sep 30, 2023 | -623,904.00 |
| Jun 30, 2023 | -494,144.00 |
| Mar 31, 2023 | -26,588.00 |
| Dec 31, 2022 | -27,026.00 |
| Sep 30, 2022 | -5,977.00 |
| Jun 30, 2022 | -22,500.00 |
| Mar 31, 2022 | 859,021.00 |
| Dec 31, 2021 | 679,675.00 |
| Sep 30, 2021 | 449,501.00 |
| Jun 30, 2021 | 10,871.00 |
| Mar 31, 2021 | -719,731.00 |
| Dec 31, 2020 | -22,488.00 |
| Sep 30, 2020 | -94,481.00 |
| Jun 30, 2020 | 158,547.00 |
| Mar 31, 2020 | -56,770.00 |
| Dec 31, 2019 | -566,294.00 |
| Sep 30, 2019 | -228,397.00 |